Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12104/66825
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGurrola-Diaz, C.M.
dc.contributor.authorSuarez-Rincon, A.E.
dc.contributor.authorVazquez-Camacho, G.
dc.contributor.authorBuonocunto-Vazquez, G.
dc.contributor.authorRosales-Quintana, S.
dc.contributor.authorWentzensen, N.
dc.contributor.authorvon Knebel Doeberitz, M.
dc.date.accessioned2015-11-19T18:51:38Z-
dc.date.available2015-11-19T18:51:38Z-
dc.date.issued2008
dc.identifier.urihttp://hdl.handle.net/20.500.12104/66825-
dc.description.abstractObjective: Cervical cancer is currently the most frequently occurring cancer among women in Mexico. Mexican cervical cancer prevention programs have been unsatisfactory in part because the tests used to diagnose precursor lesions have poor reproducibility. The implementation ofspecific biomarkers may overcome these limitations. Here, we analyzed whether immunohistochemistry for p16INK4a could improve the reproducibility of histopathological diagnoses of cervical precancerous lesions. Methods: Serial sections of 78 specimens were stained for H&E and p16INK4a and independently interpreted by three Mexican pathologists. Specimens were interpreted and categorized in two ways: 1) four diagnostic categories including negative lesions, CIN1, CIN2, and CIN3, or 2) two diagnostic categories; either lesions that do not require therapy (negative, CIN1), or lesions that require therapy (≥ CIN2). The agreement in diagnoses between pairs of observers was evaluated by kappa statistics. Results: The best concordance in diagnosing was observed with two categories and p16INK4a staining. Interestingly, the overall diagnostic discordances of higher than one CIN grade were 26.1% for H&E and 9.20% for p16INK4a (P < 0.001). Using four diagnostic categories, weighted kappa values for each pair of observers were 0.28, 0.15, and 0.36 for H&E and 0.34, 0.35, and 0.60 for p16INK4a stains. Using two diagnostic categories, kappa values were 0.36, 0.12, and 0.18 for H&E and 0.59, 0.70, and 0.59, p16INK4a stains. Conclusion: These data show that p16INK4a immunohistochemistry substantially improved the reproducibility of interpreting histological slides. This approach may result in more accurate diagnoses and improved clinical management of patients with cervical precancerous lesions in Mexico and elsewhere. © 2008 Elsevier Inc. All rights reserved.
dc.titleP16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies
dc.typeArticle
dc.identifier.doi10.1016/j.ygyno.2008.06.032
dc.relation.ispartofjournalGynecologic Oncology
dc.relation.ispartofvolume111
dc.relation.ispartofissue1
dc.relation.ispartofpage120
dc.relation.ispartofpage124
dc.subject.keywordBiomarker; Cervical intraepithelial neoplasia (CIN); Immunohistochemistry; Mexico; p16 protein/p16INK4a (cyclin-dependent kinase inhibitor); Reproducibility
dc.contributor.affiliationGurrola-Díaz, C.M., Instituto de Enfermedades Crónico-Degenerativas, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco C.P. 44340, Mexico; Suárez-Rincón, Á.E., Unidad de Investigación en Colposcopia y Patología Cervical, Hospital General Regional No. 45, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico; Vázquez-Camacho, G., Departamento de Anatomía Patológica, U.M.A.E., Centro Medico Nacional de Occidente, Guadalajara, Jalisco, Mexico; Buonocunto-Vázquez, G., Departamento de Anatomía Patológica, U.M.A.E., Centro Medico Nacional de Occidente, Guadalajara, Jalisco, Mexico; Rosales-Quintana, S., Departamento de Anatomía Patológica, U.M.A.E., Centro Medico Nacional de Occidente, Guadalajara, Jalisco, Mexico; Wentzensen, N., Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany; von Knebel Doeberitz, M., Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany
dc.subject.headingIndex Medicus;Adult;Cervical Intraepithelial Neoplasia/di [Diagnosis];Cervical Intraepithelial Neoplasia/me [Metabolism];Cervical Intraepithelial Neoplasia/pa [Pathology];Conization;Cyclin-Dependent Kinase Inhibitor p16/me [Metabolism];Eosine Yellowish-(YS)/ch [Chemistry];Female;Hematoxylin/ch [Chemistry];Humans;Immunohistochemistry;Neoplasm Staging;Observer Variation;Reproducibility of Results;Staining and Labeling/mt [Methods];Tumor Markers, Biological/me [Metabolism];Uterine Cervical Neoplasms/di [Diagnosis];Uterine Cervical Neoplasms/me [Metabolism];Uterine Cervical Neoplasms/pa [Pathology]
dc.relation.isReferencedByScopus
dc.relation.isReferencedByMEDLINE
dc.relation.isReferencedByWOS
dc.identifier.urlhttp://www.scopus.com/inward/record.url?eid=2-s2.0-52049121496&partnerID=40&md5=af7a96b9cbc5a2e9747ff834ed47f292
dc.identifier.urlhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med5&AN=18692882
Appears in Collections:Producción científica UdeG (prueba)

Files in This Item:
There are no files associated with this item.


Items in RIUdeG are protected by copyright, with all rights reserved, unless otherwise indicated.